Pac Premier
Giving Guide
You are here:  Home  >  Biotech  >  Current Article

Sienna Biopharmaceuticals cuts expenses, net losses

By   /   Wednesday, May 8th, 2019  /   Comments Off on Sienna Biopharmaceuticals cuts expenses, net losses

    Print       Email
Westlake Village-based Sienna Biopharmaceuticals reported a nearly 15 percent drop in its operating expenses for the quarter ended March 31, as it decreased research and development spending to move products through clinical trials. The pre-revenue company, which develops dermatological therapies, marked the quarter with an “End-of-Phase 2 meeting” with the U.S. Food and Drug Administration…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email